Zacks Research Cuts Earnings Estimates for Acadia Healthcare

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Research analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for shares of Acadia Healthcare in a research report issued on Monday, May 26th. Zacks Research analyst R. Sipani now forecasts that the company will earn $0.69 per share for the quarter, down from their prior forecast of $0.77. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare's Q3 2025 earnings at $0.87 EPS, Q4 2025 earnings at $0.71 EPS, FY2025 earnings at $2.67 EPS, Q1 2026 earnings at $0.48 EPS, Q2 2026 earnings at $0.76 EPS, Q4 2026 earnings at $0.78 EPS, FY2026 earnings at $2.96 EPS, Q1 2027 earnings at $0.67 EPS and FY2027 earnings at $3.41 EPS.

Other equities research analysts also recently issued reports about the stock. Barclays decreased their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 14th. Royal Bank of Canada decreased their target price on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Mizuho lowered their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. KeyCorp lowered their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Finally, Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Trading Down 4.1%

Shares of NASDAQ:ACHC traded down $0.93 during trading on Thursday, reaching $21.72. 530,291 shares of the stock were exchanged, compared to its average volume of 1,714,160. Acadia Healthcare has a 12-month low of $20.36 and a 12-month high of $82.41. The firm's 50-day moving average price is $25.09 and its 200 day moving average price is $34.24. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market cap of $2.00 billion, a price-to-earnings ratio of 7.13, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare's revenue for the quarter was up .3% on a year-over-year basis. During the same quarter last year, the business earned $0.84 EPS.

Institutional Trading of Acadia Healthcare

Institutional investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. lifted its stake in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after buying an additional 454,044 shares during the last quarter. Nisa Investment Advisors LLC raised its stake in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Fifth Third Bancorp lifted its holdings in Acadia Healthcare by 56.0% in the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after purchasing an additional 454 shares during the period. Blue Trust Inc. increased its stake in Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after buying an additional 345 shares during the period. Finally, KBC Group NV raised its position in shares of Acadia Healthcare by 50.1% during the 4th quarter. KBC Group NV now owns 4,035 shares of the company's stock worth $160,000 after buying an additional 1,347 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.